Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SAVAYSA 60 MG TABLET

EDOXABAN TOSYLATE
$12.4609per EA

Strength

60 mg/1

Manufacturer

Daiichi Sankyo Inc.

NDC

65597020305

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

7/20/2022

Active Ingredients

EDOXABAN TOSYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA206316

On Market Since

1/12/2015

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+0.7%

All

+47.1%

Generic Alternatives

1 alternative • Same active ingredient

SAVAYSA 60 MG TABLET
Brand
65597020390•Daiichi Sankyo Inc.
$12.4609

Related Drugs

Same classification

XARELTO 1 MG/ML SUSPENSION
Brand
50458057501•Janssen Pharmaceuticals Inc.
$3.7634
per ML
ELIQUIS 2.5 MG TABLET
Brand
00003089321•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 2.5 MG TABLET
Brand
00003089331•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 5 MG TABLET
Brand
00003089421•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089431•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089470•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
XARELTO 2.5 MG TABLET
Brand
50458057710•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057718•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 2.5 MG TABLET
Brand
50458057760•Janssen Pharmaceuticals Inc.
$9.7866
per EA
XARELTO 10 MG TABLET
Brand
50458058010•Janssen Pharmaceuticals Inc.
$19.5380
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy